Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
20,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer |
138,151 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director |
20,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
20,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Lee Jacks Director |
10,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
534,787 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
168,387 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
89,762 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
236,610 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Sharpless Norman Director |
20,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
124,762 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
114,482 | $0 | $0 | 0 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-18 4:15 pm |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
20,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:59 pm |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
1,337 | $2.5077 | $3,353 | 112,614 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:58 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
2,475 | $2.5077 | $6,207 | 128,012 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:57 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
2,475 | $2.5077 | $6,207 | 159,312 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:55 pm |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
2,638 | $2.5077 | $6,615 | 242,045 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:54 pm |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
527 | $2.5077 | $1,322 | 187,718 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-08 5:53 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
7,662 | $2.5077 | $19,214 | 549,674 (Direct) |
View |
| 2024-05-23 Sale |
2024-05-24 4:15 pm |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer |
5,826 | $4.2678 | $24,864 | 109,825 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:12 pm |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
8,151 | $4.7888 | $39,034 | 78,951 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:11 pm |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
8,151 | $4.7888 | $39,034 | 153,245 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:10 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
8,151 | $4.7888 | $39,034 | 95,487 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:08 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
8,151 | $4.7888 | $39,034 | 161,787 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:07 pm |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
8,151 | $4.7888 | $39,034 | 209,683 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 4:06 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
37,258 | $4.7888 | $178,421 | 452,336 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
10,000 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer |
6,674 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director |
15,889 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
14,389 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Lee Jacks Director |
10,000 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
196,287 | $0 | 0 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
181,400 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
19,331 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
87,450 | $0 | 0 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
17,900 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
26,035 | $0 | 0 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
20,600 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
21,150 | $0 | 0 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
17,900 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
14,232 | $0 | 0 (Direct) |
View |
| 2024-09-18 Option Award |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
16,100 | $0 | 0 (Direct) |
View |
| 2024-09-18 Equity Swap |
2024-09-18 4:15 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
185,358 | $0 | 0 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:34 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
35,000 | $0 | 113,951 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:32 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
35,000 | $0 | 130,487 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:27 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. Chief Legal & People Officer |
35,000 | $0 | 144,825 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:26 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
35,000 | $0 | 244,683 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:24 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Umstead John W. V Chief Financial Officer |
35,000 | $0 | 188,245 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 5:22 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
105,000 | $0 | 557,336 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:43 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | Sharpless Norman Director |
40,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:42 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
40,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:41 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
40,000 | $0 | 235,358 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:40 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | Lee Jacks Director |
40,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:39 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director |
40,000 | $0 | 65,889 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:37 pm |
N/A 2034-06-13 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
40,000 | $0 | 64,389 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 4:10 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Thomas Monica R. General Counsel |
37,500 | $0 | 115,651 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 4:09 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
100,000 | $0 | 217,834 (Direct) |
View |